Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

Weight loss drugs continue to make headlines.  A new study conducted by researchers from the University of Southern ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

Semaglutide could help people drink less alcohol. Semaglutide, a medication widely used for diabetes and weight loss, may offer another ... Over the nine-week trial, participants taking ...

Discover Zealand Pharma's Q4 2024 earning highlights, key obesity pipeline advancements, and future plans for petrelintide and dapiglutide.

It’s possible to experience significant, disruptive side effects while taking semaglutide for weight loss. Clinical trials have reported discontinuation rates (people quitting the medication ...

Wegovy is a GLP-1 agonist containing semaglutide ... also lost 12 to 15 pounds in clinical trials, though it’s not a weight loss medication. Starting dose: 0.25 mg weekly for 4 weeks.